Testosterone pellet surface area relates to effectiveness more than dose.

Within 2 weeks of pellet implantation, testosterone levels rose over two times the baseline level in both groups.

• Both cohorts demonstrated a greater than 2x increase in serum testosterone from baseline within 2 weeks of implantation.
• The response was observed across both the lower-dose/higher-surface-area group and the higher-dose/lower-surface-area group.
• The elevation in T levels was sustained over the 3-month evaluation period.

The cohort administered the lowest testosterone dose but highest surface area had the greatest response whether calculated as peak change or analyzed according to age-adjusted values.

• Two groups were compared: one receiving small individual pellets with higher total surface area at a lower dose, and another receiving a higher dose with lower surface area.
• Greatest response was measured both as peak change in serum testosterone and as age-adjusted values.
• This finding suggests surface area is a more important determinant of testosterone delivery than total dose.

Increasing pellet surface area resulted in fewer extrusions compared to subjects receiving higher dose pellets with lower surface area.

• Pellet extrusion is a known complication of testosterone pellet implantation.
• The higher surface area/lower dose group experienced fewer extrusions than the lower surface area/higher dose group.
• No adverse events were reported in the higher surface area group.

Current guidelines for testosterone pellet dosing have been absent and men are often overdosed.

• The authors note that guidelines for pellet dosing have been absent.
• The study was motivated by the observation that men are 'often overdosed with T' using current pellet administration practices.
• The study evaluated the effect of pellet dose versus surface area on blood levels over 3 months in healthy men.

Administering testosterone pellets using methods that maximize total pellet surface area appears to have no negative consequences.

• No adverse events were reported with the high surface area pellet approach.
• Higher serum T levels were achieved compared to subjects receiving higher dose/lower surface area pellets.
• The authors conclude that maximizing total pellet surface area is a viable dosing strategy.